23andMe Patents

Patent portfolio assigned to 23andMe (verified via public assignee records). Estimated patent count: 122. Consumer genetics company. GSK was a multi-year drug-discovery collaboration partner ($300M equity investment; partnership ran 2018-2023). 23andMe, Inc. has a Justia patent assignee page; ~122 granted US patents per GreyB analysis.